Aliqopa is a prescription drug used to treat adults with follicular lymphoma (FL) who have received atleast two prior systemic therapies. To buy Aliqopa or to know its price contact 3S Corporation.
Manufacture :- Bayer Healthcare Pharmaceuticals Inc
Strength Available :- 60 mg
Form :- Injection
Dosage :- Recommende dosage for (FL) is 60 mg via 1-hour IV infusion on Days 1, 8, and 15 of a 28-day treatment cycle on an intermittent schedule (3 weeks on and 1 week off).Duration of Therapy: Until disease progression or unacceptable toxicity.
Storage :- Store at 2ºC to 8ºC
Is The Medicine FDA Approved :- Yes
Date of Approval :- September 14, 2017
Common side effects are Black, tarry stools, bleeding gums, blood in the urine or tools, blurred vision, chest pain, chills, cough, cracks in the skin, dizziness, dry mouth, fatigue, flushed, dry skin, fruit-like breath odor, headache,increased hunger, increased thirst, increased , urination, loss of heat from the body, lower back or side pain, nausea, nervousness, painful or difficult urination, pale skin, pinpoint red spots on the skin, pounding in the ears, red, swollen skin, scaly skin, slow or fast heartbeat, sneezing, sore throat, sores, ulcers, or white spots on the lips or in the mouth, stomach pain, sweating, swollen glands, tightness in the chest, troubled breathing, unexplained weight loss, unusual bleeding or bruising, unusual tiredness or weakness, vomiting.
Pack of 1 vial
3S Corporation is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of Aliqopa Copanlisib 60 mg based in India - To buy Aliqopa Copanlisib 60 mg or know its cost price contact us here.
We supply & sell Aliqopa Copanlisib 60 mg for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.